This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld

Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals
J. Virol. Li et al. 83: 1045

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 - Table S1 (gp120 (YU2) variable region-derived peptides used as competitor in the inhibition of neutralization assay.)
    Table S2 (gp41 peptides used as competitor in the inhibition of neutralization assay.)
    Zipped PDF file, 30K.
  • Supplemental file 2 - Fig. S1 (HIV-1 envelope glycoprotein neutrallization surfaces and gp120 adsorption process.)
    Zipped TIF file, 1.2MB.
  • Supplemental file 3 - Fig. S2 (Potency and breadth of neutralization by selected HIV+ sera.)
    Zipped EPS file, 376K.
  • Supplemental file 4 - Fig. S3 (Verification of protein coupling, structural integrity of coupled gp120, and efficiency of antibody adsorption.)
    Zipped EPS file, 980K.
  • Supplemental file 5 - Fig. S4 (CD4bs antibody specificity of serum.)
    Zipped EPS file, 245K.
  • Supplemental file 6 - Fig. S5 (gp1201420R mutant protein selectively eliminates binding of monoclonal antibodies directed toward the coreceptor binding regions.)
    Zipped EPS file, 195K.
  • Supplemental file 7 - Fig. S6 (Levels of MPER-binding antibodies in the HIV+ sera detected by ELISA.)
    Zipped EPS file, 241K.




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld